X-ray and mammography equipment vendor Fischer Imaging reported revenue of $19.8 million for the second quarter, ended June 30, 2004, a 64% increase over revenue of $12.1 million for the same period in 2003. Net income for the 2004 second quarter was
X-ray and mammography equipment vendor Fischer Imaging reported revenue of $19.8 million for the second quarter, ended June 30, 2004, a 64% increase over revenue of $12.1 million for the same period in 2003. Net income for the 2004 second quarter was $3.2 million compared with a net loss of $2.4 million in the comparable 2003 period. Results were bolstered, however, by an amended 2002 patent settlement agreement. The amendment provided a one-time payment totaling $4.3 million in lieu of six remaining $0.9 million payments that were due annually through 2010. The gross margin on product sales was 28.5% in the second quarter of 2004, down from 33.1% in the second quarter of 2003. The negative service margin was primarily a result of increased parts usage associated with installed SenoScan systems. The company's quality improvement initiatives and eventual contract maintenance revenue increases are expected to favorably impact both product and service margins over time.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.